PT  - JOURNAL ARTICLE
AU  - Bahar, Burak
AU  - Simpson, Joelle N.
AU  - Biddle, Cara
AU  - Campbell, Andrew
AU  - Dome, Jeffrey S.
AU  - DeBiasi, Roberta L.
AU  - Mowbray, Catriona
AU  - Marguilies, Stefanie
AU  - Sherman, Adrienne
AU  - Reuben, Jacqueline
AU  - Delaney, Meghan
TI  - Estimated SARS-CoV-2 Seroprevalence in Healthy Children and Those with Chronic Illnesses in The Washington Metropolitan Area as of October 2020
AID  - 10.1101/2021.01.30.21250830
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.01.30.21250830
4099  - http://medrxiv.org/content/early/2021/02/01/2021.01.30.21250830.short
4100  - http://medrxiv.org/content/early/2021/02/01/2021.01.30.21250830.full
AB  - The estimated SARS-CoV-2 seroprevalence in children was found to be 9.46% for the Washington Metropolitan area. Hispanic/Latinx individuals were found to have higher odds of seropositivity. While chronic medical conditions were not associated with having antibodies, previous fever and body aches were predictive symptoms.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was reviewed and approved by both Childrens National Hospital and District of Columbia Department of Health Institutional Review Boards.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDeidentified data will be provided upon approval by the institutional review boards.